C-reactive protein, an early marker of community-acquired sepsis resolution: a multi-center prospective observational study

被引:89
作者
Povoa, Pedro [1 ,2 ]
Teixeira-Pinto, Armando M. [3 ]
Carneiro, Antonio H. [4 ]
机构
[1] CHLO, Sao Francisco Xavier Hosp, Polyvalent Intens Care Unit, P-1449005 Lisbon, Portugal
[2] Univ Nova Lisboa, Fac Med Sci, CEDOC, P-1169056 Lisbon, Portugal
[3] Univ Porto, Fac Med, CINTESIS, Dept Biostat & Med Informat, P-4200319 Oporto, Portugal
[4] Santo Antonio Hosp, P-4099001 Oporto, Portugal
来源
CRITICAL CARE | 2011年 / 15卷 / 04期
关键词
VENTILATOR-ASSOCIATED PNEUMONIA; PULMONARY INFECTION SCORE; ACUTE-PHASE PROTEINS; INTENSIVE-CARE-UNIT; ANTIMICROBIAL THERAPY; ANTIBIOTIC-THERAPY; ILL PATIENTS; MANAGEMENT; IDENTIFICATION; PROCALCITONIN;
D O I
10.1186/cc10313
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Introduction: C-reactive protein (CRP) has been shown to be a valuable marker in the diagnosis of infection and in monitoring its response to antibiotics. Our objective was to evaluate serial CRP measurements after prescription of antibiotics to describe the clinical course of Community-Acquired Sepsis admitted to intensive care units (ICU). Methods: During a 12-month period a multi-center, prospective, observational study was conducted, segregating adults with Community-Acquired Sepsis. Patients were followed-up during the first five ICU days, day of ICU discharge or death and hospital outcome. CRP-ratio was calculated in relation to Day 1 CRP concentration. Patients were classified according to the pattern of CRP-ratio response to antibiotics: fast response if Day 5 CRP-ratio was < 0.4, slow response if Day 5 CRP-ratio was between 0.4 and 0.8, and no response if Day 5 CRP-ratio was > 0.8. Comparison between survivors and non-survivors was performed. Results: A total of 891 patients (age 60 +/- 17 yrs, hospital mortality 38%) were studied. There were no significant differences between the CRP of survivors and non-survivors until Day 2 of antibiotic therapy. On the following three days, CRP of survivors was significantly lower (P < 0.001). After adjusting for the Simplified Acute Physiology Score II and severity of sepsis, the CRP course was significantly associated with mortality (ORCRP-ratio = 1.03, confidence interval (95%)= (1.02, 1.04), P < 0.001). The hospital mortality of patients with fast response, slow response and no response patterns was 23%, 30% and 41%, respectively (P = 0.001). No responders had a significant increase on the odds of death (OR = 2.5, CI95% = (1.6, 4.0), P < 0.001) when compared with fast responders. Conclusions: Daily CRP measurements after antibiotic prescription were useful as early as Day 3 in identification of Community-Acquired Sepsis patients with poor outcome. The rate of CRP decline during the first five ICU days was markedly associated with prognosis. The identification of the pattern of CRP-ratio response was useful in the recognition of the individual clinical course.
引用
收藏
页数:10
相关论文
共 43 条
  • [1] [Anonymous], 2004, Applied Longitudinal Analysis
  • [2] AMERICAN-COLLEGE OF CHEST PHYSICIANS SOCIETY OF CRITICAL CARE MEDICINE CONSENSUS CONFERENCE - DEFINITIONS FOR SEPSIS AND ORGAN FAILURE AND GUIDELINES FOR THE USE OF INNOVATIVE THERAPIES IN SEPSIS
    BONE, RC
    BALK, RA
    CERRA, FB
    DELLINGER, RP
    FEIN, AM
    KNAUS, WA
    SCHEIN, RMH
    SIBBALD, WJ
    ABRAMS, JH
    BERNARD, GR
    BIONDI, JW
    CALVIN, JE
    DEMLING, R
    FAHEY, PJ
    FISHER, CJ
    FRANKLIN, C
    GORELICK, KJ
    KELLEY, MA
    MAKI, DG
    MARSHALL, JC
    MERRILL, WW
    PRIBBLE, JP
    RACKOW, EC
    RODELL, TC
    SHEAGREN, JN
    SILVER, M
    SPRUNG, CL
    STRAUBE, RC
    TOBIN, MJ
    TRENHOLME, GM
    WAGNER, DP
    WEBB, CD
    WHERRY, JC
    WIEDEMANN, HP
    WORTEL, CH
    [J]. CRITICAL CARE MEDICINE, 1992, 20 (06) : 864 - 874
  • [3] Usefulness of consecutive C-reactive protein measurements in follow-up of severe community-acquired pneumonia
    Bruns, A. H. W.
    Oosterheert, J. J.
    Hak, E.
    Hoepelman, A. I. M.
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2008, 32 (03) : 726 - 732
  • [4] Effect of point of care testing for C reactive protein and training in communication skills on antibiotic use in lower respiratory tract infections: cluster randomised trial
    Cals, Jochen W. L.
    Butler, Christopher C.
    Hopstaken, Rogier M.
    Hood, Kerenza
    Dinant, Geert-Jan
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2009, 338 : 1112 - 1115
  • [5] Clinical review: The role of biomarkers in the diagnosis and management of community-acquired pneumonia
    Christ-Crain, Mirjam
    Opal, Steven M.
    [J]. CRITICAL CARE, 2010, 14 (01)
  • [6] Usefulness of C-reactive protein in monitoring the severe community-acquired pneumonia clinical course
    Coelho, Luis
    Póvoa, Pedro
    Almeida, Eduardo
    Fernandes, Antero
    Mealha, Rui
    Moreira, Pedro
    Sabino, Henrique
    [J]. CRITICAL CARE, 2007, 11 (04)
  • [7] Resolution of infectious parameters after antimicrobial therapy in patients with ventilator-associated pneumonia
    Dennesen, PJW
    van der Ven, AJAM
    Kessels, AGH
    Ramsay, C
    Bonten, MJM
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2001, 163 (06) : 1371 - 1375
  • [8] Mechanisms of disease: Acute-phase proteins and other systemic responses to inflammation
    Gabay, C
    Kushner, I
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (06) : 448 - 454
  • [9] CDC DEFINITIONS FOR NOSOCOMIAL INFECTIONS, 1988
    GARNER, JS
    JARVIS, WR
    EMORI, TG
    HORAN, TC
    HUGHES, JM
    [J]. AMERICAN JOURNAL OF INFECTION CONTROL, 1988, 16 (03) : 128 - 140
  • [10] Hutt E, 2002, J FAM PRACTICE, V51, P709